Scientists at the University of Sheffield have found that an arthritis drug could be effective in the treatment of blood cancer patients. Polycythemia vera is a type of blood cancer which affects 3,000 people a year. Current treatments dont slow progression of the disease and provide little relief from symptoms.The University of Sheffield research group found that a commonly used to treatment for arthiritis, Methotrixate, could also slow the blood cancer disease by directly inhibiting the molecular pathway responsible. Sheffield Live! reporter Simon Thake spoke to Martin Zeidler, of the University of Sheffield’s Department of Biomedical Science.